154 related articles for article (PubMed ID: 23831255)
1. Role of angiotensin II type 1 receptor-activating antibodies in solid organ transplantation.
Reinsmoen NL
Hum Immunol; 2013 Nov; 74(11):1474-7. PubMed ID: 23831255
[TBL] [Abstract][Full Text] [Related]
2. Anti-angiotensin type 1 receptor antibodies associated with antibody mediated rejection in donor HLA antibody negative patients.
Reinsmoen NL; Lai CH; Heidecke H; Haas M; Cao K; Ong G; Naim M; Wang Q; Mirocha J; Kahwaji J; Vo AA; Jordan SC; Dragun D
Transplantation; 2010 Dec; 90(12):1473-7. PubMed ID: 21030904
[TBL] [Abstract][Full Text] [Related]
3. The influence of non-HLA antibodies directed against angiotensin II type 1 receptor (AT1R) on early renal transplant outcomes.
Banasik M; Boratyńska M; Kościelska-Kasprzak K; Kamińska D; Bartoszek D; Zabińska M; Myszka M; Zmonarski S; Protasiewicz M; Nowakowska B; Hałoń A; Chudoba P; Klinger M
Transpl Int; 2014 Oct; 27(10):1029-38. PubMed ID: 24909812
[TBL] [Abstract][Full Text] [Related]
4. Investigation of Serum Angiotensin II Type 1 Receptor Antibodies at the Time of Renal Allograft Rejection.
Lee H; Kim JI; Moon IS; Chung BH; Yang CW; Kim Y; Han K; Oh EJ
Ann Lab Med; 2015 May; 35(3):314-20. PubMed ID: 25932439
[TBL] [Abstract][Full Text] [Related]
5. AT2R autoantibodies block angiotensin II and AT1R autoantibody-induced vasoconstriction.
Liles C; Li H; Veitla V; Liles JT; Murphy TA; Cunningham MW; Yu X; Kem DC
Hypertension; 2015 Oct; 66(4):830-5. PubMed ID: 26259590
[TBL] [Abstract][Full Text] [Related]
6. Anti-angiotensin type 1 receptor antibodies associated with antibody-mediated rejection in patients without preformed HLA-donor-specific antibody.
In JW; Park H; Rho EY; Shin S; Park KU; Park MH; Song EY
Transplant Proc; 2014 Dec; 46(10):3371-4. PubMed ID: 25498054
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection.
Dragun D; Müller DN; Bräsen JH; Fritsche L; Nieminen-Kelhä M; Dechend R; Kintscher U; Rudolph B; Hoebeke J; Eckert D; Mazak I; Plehm R; Schönemann C; Unger T; Budde K; Neumayer HH; Luft FC; Wallukat G
N Engl J Med; 2005 Feb; 352(6):558-69. PubMed ID: 15703421
[TBL] [Abstract][Full Text] [Related]
8. Humoral immunity in hand transplantation: anti-HLA and non-HLA response.
Banasik M; Jabłecki J; Boratyńska M; Kamińska D; Kościelska-Kasprzak K; Bartoszek D; Chełmoński A; Hałoń A; Baran W; Klinger M
Hum Immunol; 2014 Aug; 75(8):859-62. PubMed ID: 24952209
[TBL] [Abstract][Full Text] [Related]
9. The impact of angiotensin II type 1 receptor antibodies on post-heart transplantation outcome in Heart Mate II bridged recipients.
Urban M; Slavcev A; Gazdic T; Ivak P; Besik J; Netuka I
Interact Cardiovasc Thorac Surg; 2016 Mar; 22(3):292-7. PubMed ID: 26675563
[TBL] [Abstract][Full Text] [Related]
10. Non-HLA antibodies in solid organ transplantation: recent concepts and clinical relevance.
Dragun D; Catar R; Philippe A
Curr Opin Organ Transplant; 2013 Aug; 18(4):430-5. PubMed ID: 23838648
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up of non-HLA and anti-HLA antibodies: incidence and importance in renal transplantation.
Banasik M; Boratyńska M; Kościelska-Kasprzak K; Mazanowska O; Bartoszek D; Zabińska M; Myszka M; Nowakowska B; Hałoń A; Szyber P; Patrzałek D; Klinger M
Transplant Proc; 2013 May; 45(4):1462-5. PubMed ID: 23726597
[TBL] [Abstract][Full Text] [Related]
12. Circulating angiotensin type II receptor: Possible marker for antibody mediated rejection after renal transplantation?
Kimball PM; Gupta G; McDougan F
Hum Immunol; 2017 Oct; 78(10):629-633. PubMed ID: 28614703
[TBL] [Abstract][Full Text] [Related]
13. The impact of Angiotensin II Type 1 Receptor antibodies on morbidity and mortality in Heart Mate II supported recipients.
Marian U; Slavcev A; Gazdic T; Ivak P; Netuka I
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Dec; 160(4):518-523. PubMed ID: 27132810
[TBL] [Abstract][Full Text] [Related]
14. Prediction of organ transplant rejection by HLA-specific and non-HLA antibodies--brief literature review.
Slavcev A
Int J Immunogenet; 2013 Apr; 40(2):83-7. PubMed ID: 22708882
[TBL] [Abstract][Full Text] [Related]
15. Humoral responses directed against non-human leukocyte antigens in solid-organ transplantation.
Dragun D
Transplantation; 2008 Oct; 86(8):1019-25. PubMed ID: 18946337
[TBL] [Abstract][Full Text] [Related]
16. Renal ischemia and transplantation predispose to vascular constriction mediated by angiotensin II type 1 receptor-activating antibodies.
Lukitsch I; Kehr J; Chaykovska L; Wallukat G; Nieminen-Kelhä M; Batuman V; Dragun D; Gollasch M
Transplantation; 2012 Jul; 94(1):8-13. PubMed ID: 22691955
[TBL] [Abstract][Full Text] [Related]
17. Non-HLA antibodies targeting vascular receptors enhance alloimmune response and microvasculopathy after heart transplantation.
Hiemann NE; Meyer R; Wellnhofer E; Schoenemann C; Heidecke H; Lachmann N; Hetzer R; Dragun D
Transplantation; 2012 Nov; 94(9):919-24. PubMed ID: 23034559
[TBL] [Abstract][Full Text] [Related]
18. Impact and production of Non-HLA-specific antibodies in solid organ transplantation.
Zhang X; Reinsmoen NL
Int J Immunogenet; 2020 Jun; 47(3):235-242. PubMed ID: 32426916
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II signaling via type 2 receptors in a human model of vascular hyporeactivity: implications for hypertension.
Calò LA; Schiavo S; Davis PA; Pagnin E; Mormino P; D'Angelo A; Pessina AC
J Hypertens; 2010 Jan; 28(1):111-8. PubMed ID: 19797979
[TBL] [Abstract][Full Text] [Related]
20. Hepatocyte growth factor and antibodies to HLA and MICA antigens in heart transplant recipients.
Pavlova YA; Malek I; Honsova E; Netuka I; Sochman J; Lodererova A; Kolesar L; Striz I; Skibova J; Slavcev A
Tissue Antigens; 2010 Nov; 76(5):380-6. PubMed ID: 20604893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
